Royal London Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $283K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $1.88M | Hold |
|
|||||
|
2024
Q1 | $2.38M | Sell |
|
|||||
|
2023
Q4 | $2.3M | Sell |
|
|||||
|
2023
Q3 | $2.93M | Buy |
|
|||||
|
2023
Q2 | $2.87M | Hold |
|
|||||
|
2023
Q1 | $3.62M | Buy |
|
|||||
|
2022
Q4 | $2.86M | Buy |
|
|||||
|
2022
Q3 | $2.4M | Sell |
|
|||||
|
2022
Q2 | $2.94M | Sell |
|
|||||
|
2022
Q1 | $3.49M | Buy |
|
|||||
|
2021
Q4 | $4.48M | Hold |
|
|||||
|
2021
Q3 | $4.42M | Hold |
|
|||||
|
2021
Q2 | $3.82M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $3.28M | Buy |
|
|||||
|
2020
Q3 | $2.59M | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $2.7M | Buy |
|
|||||
|
2018
Q3 | $3.52M | Sell |
|
|||||
|
2018
Q2 | $3.38M | Buy |
|
|||||
|
2016
Q2 | $2.72M | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $2.15M | Sell |
|
|||||
|
2015
Q3 | $2.08M | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $1.99M | Sell |
|
|||||
|
2014
Q1 | $2.07M | Buy |
|